COLLEEN TAYLOR: Open Payments
NPI 1437147253 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,419 in 121 payments from 17 companies in 2025. Trend: 2023 $1,879 · 2024 $2,520 · 2025 $2,419
Food & beverage: $2,419
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $716 |
| ABBVIE INC. | 20 | $320 |
| Neurocrine BioSciences, Inc. | 11 | $191 |
| Alkermes, Inc. | 10 | $166 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| E.R. Squibb & Sons, L.L.C. | 9 | $153 |
| Lundbeck LLC | 8 | $139 |
| Janssen Pharmaceuticals, Inc | 5 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
Products named: CAPLYTA, VRAYLAR, REXULTI, INGREZZA, ARISTADA, COBENFY, TRINTELLIX, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
